SMHX VanEck Fabless Semiconductor ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 16.64% |
| AVGO | 12.67% |
| AMD | 7.09% |
| ALAB | 6.18% |
| MRVL | 6.15% |
| ARM | 5.87% |
| QCOM | 5.12% |
| MPWR | 4.33% |
| SITM | 4.13% |
| SNPS | 4.00% |
ETF Analysis
Fund Overview
VanEck Fabless Semiconductor ETF (SMHX) currently reports 23 stock positions (subject to change), placing it in the concentrated range by holdings breadth. The top line-up is NVDA (16.64%), AVGO (12.67%), AMD (7.09%), with NVDA as the largest single weight at 16.64%. Together, the top three holdings account for 36.40%, which signals meaningful concentration at the top of the book, where a small number of names can drive outsized swings in fund performance. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.
Profitability & Capital Efficiency
From a capital efficiency perspective, ROIC is 34.99%, WACC is 15.39%, and the economic spread is 19.61%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 31.97% and ROA at 14.29%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
Multiple analysis puts the portfolio at trailing P/E of 58.51, forward P/E of 37.03, PEG of 1.83. The spread from trailing to forward multiple is wide enough to suggest earnings momentum is a meaningful part of the current valuation case. On a PEG basis, valuation is in the middle ground — fair for the growth on offer, with the return case resting on earnings delivery rather than re-rating. The current ratio of 4.37 indicates holdings are well-positioned to meet near-term obligations. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.
Margins & Cash Generation
On the margin front: gross margin sits at 67.58%, operating margin at 26.64%, and free cash flow margin at 30.14%. At this gross margin level, the portfolio's holdings demonstrate significant pricing power and production efficiency. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. At this FCF margin level, the underlying holdings have considerable financial flexibility without reliance on external financing. The margin trifecta here — strong at gross, operating, and free cash flow levels — is a hallmark of competitively advantaged businesses.
Growth & Forward Outlook
On the forward picture: TTM revenue growth of 44.61% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 58.0% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest the target set points to a fairly constrained upside profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyAcross the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.